Kaken Pharmaceutical Co Ltd

TSE:4521

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kaken Pharmaceutical Co Ltd's stock price target?

Price Target

4 590 JPY

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 590 JPY with a low forecast of 3 636 JPY and a high forecast of 5 670 JPY.

What is Kaken Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

-5%

For the last 13 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's revenue is 1%. The projected CAGR for the next 3 years is -5%.

What is Kaken Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

-3%

For the last 13 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's operating income is 3%. The projected CAGR for the next 13 years is -3%.

What is Kaken Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

-56%

For the last 13 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's net income is 4%. The projected CAGR for the next 3 years is -56%.